A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients

BACKGROUND: Myocardial infarction is the main mortality cause in patients with type 2 diabetes (T2DM). Endothelial dysfunction due to reduced bioavailability of nitric oxide (NO) is an early step of atherogenesis. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NO synthesis, and it...

Descripción completa

Detalles Bibliográficos
Autores principales: Mannino, Gaia Chiara, Pezzilli, Serena, Averta, Carolina, Fuoco, Anastasia, Spiga, Rosangela, Mancuso, Elettra, Di Fatta, Concetta, Perticone, Francesco, Prudente, Sabrina, Trischitta, Vincenzo, Andreozzi, Francesco, Sesti, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693196/
https://www.ncbi.nlm.nih.gov/pubmed/31409409
http://dx.doi.org/10.1186/s12933-019-0906-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693196/
https://www.ncbi.nlm.nih.gov/pubmed/31409409
http://dx.doi.org/10.1186/s12933-019-0906-1

Ejemplares similares